Cite
[Malignant superior vena cava syndrome: why refrain from vascular stenting?].
MLA
Greillier, L., et al. “[Malignant Superior Vena Cava Syndrome: Why Refrain from Vascular Stenting?].” Revue Des Maladies Respiratoires, vol. 26, no. 7, Sept. 2009, pp. 719–21. EBSCOhost, https://doi.org/10.1016/s0761-8425(09)72421-0.
APA
Greillier, L., Vidal, V., & Barlési, F. (2009). [Malignant superior vena cava syndrome: why refrain from vascular stenting?]. Revue Des Maladies Respiratoires, 26(7), 719–721. https://doi.org/10.1016/s0761-8425(09)72421-0
Chicago
Greillier, L, V Vidal, and F Barlési. 2009. “[Malignant Superior Vena Cava Syndrome: Why Refrain from Vascular Stenting?].” Revue Des Maladies Respiratoires 26 (7): 719–21. doi:10.1016/s0761-8425(09)72421-0.